Gier B, Matveyenko AV, Kirakossian D et al
Another GLP agonist, lixisenatide (which is not approved for obesity), improved motor function in early Parkinsons disease (Meissner WG et al, N Eng J Med 2024;390:11761185)
Semaglutide was initiated at a dose of 0.25 mg weekly for the initial month and elevated to 0.5 mg weekly
Had my gallbladder removed years before that
Backed by 2025 research showing potential for 2-4 pounds of weekly fat loss when paired with diet and exercise, mega injections are a science-supported ally in your journey to sustainable wellness
This collaboration assists in establishing realistic objectives, timing a safe schedule, and increasing the probability of results that appear and feel good